| Tavi J Madden-leduc, DO | |
|
1000 4th St Sw, Mason City, IA 50401-2800 | |
| (641) 422-7234 | |
| (641) 422-6373 |
| Full Name | Tavi J Madden-leduc |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1000 4th St Sw, Mason City, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407889272 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 3705 (Iowa) | Primary |
| Entity Name | North Iowa Mercy Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780278242 PECOS PAC ID: 7810809076 Enrollment ID: O20031105000273 |
News Archive
Precise diagnosis of disease and developmental syndromes often depends on understanding the genetics underlying them. Most cases of early onset hearing loss are genetic in origin but there are many different forms. Heretofore, it has been difficult to identify the gene responsible for the hearing loss of each affected child, because the critical mutations differ among countries and populations.
Alzheimer's disease has long been marked by progress - but not the kind of progress the medical community seeks. It is the most common form of dementia among older Americans, and its risk increases with increasing age; for those living with the disease, its ravages get worse over time; and as we move into the 21st century, it will place a greater and greater burden on society.
Walking briskly or cycling for the recommended 150 minutes a week can reduce a person's risk of developing type 2 diabetes by up to 26%, according to new research by UCL and the University of Cambridge.
A team led by Professor Patrick Labonté at the Institut National de la Recherche Scientifique in Montreal, Canada has identified the role of a key process in the replication cycle of the hepatitis D virus, an infection that is still very difficult to cure and affects 15 to 20 million people worldwide.
Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tavi J Madden-leduc, DO 621 S Illinois Ave, Suite 103, Mason City, IA 50401-5489 Ph: (641) 494-3041 | Tavi J Madden-leduc, DO 1000 4th St Sw, Mason City, IA 50401-2800 Ph: (641) 422-7234 |
News Archive
Precise diagnosis of disease and developmental syndromes often depends on understanding the genetics underlying them. Most cases of early onset hearing loss are genetic in origin but there are many different forms. Heretofore, it has been difficult to identify the gene responsible for the hearing loss of each affected child, because the critical mutations differ among countries and populations.
Alzheimer's disease has long been marked by progress - but not the kind of progress the medical community seeks. It is the most common form of dementia among older Americans, and its risk increases with increasing age; for those living with the disease, its ravages get worse over time; and as we move into the 21st century, it will place a greater and greater burden on society.
Walking briskly or cycling for the recommended 150 minutes a week can reduce a person's risk of developing type 2 diabetes by up to 26%, according to new research by UCL and the University of Cambridge.
A team led by Professor Patrick Labonté at the Institut National de la Recherche Scientifique in Montreal, Canada has identified the role of a key process in the replication cycle of the hepatitis D virus, an infection that is still very difficult to cure and affects 15 to 20 million people worldwide.
Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong
› Verified 7 days ago
Dr. Satinderjit Singh, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-7234 Fax: 641-428-6373 | |
Paul H Gordon, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1010 4th St Sw, Mason City, IA 50401 Phone: 641-422-6020 Fax: 641-422-7803 | |
Dr. Brian Michael Kuchay, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 621 S Illinois Ave, Mason City, IA 50401 Phone: 641-428-7234 | |
William I Parker, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 4th St Sw, Suite Er, Mason City, IA 50401 Phone: 641-422-7234 Fax: 641-422-6373 | |
Dr. Rajendra Singh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Suite Er, Mason City, IA 50401 Phone: 641-422-7234 Fax: 641-422-6373 | |
Dr. Matthew J Schiller, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 4th St Sw, Suite Er, Mason City, IA 50401 Phone: 641-422-7234 Fax: 641-422-6373 |